Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.260
-0.070 (-3.00%)
May 15, 2026, 4:00 PM EDT - Market closed
Lipocine Market Cap
Lipocine has a market cap or net worth of $18.14 million as of May 18, 2026. Its market cap has decreased by -4.54% in one year.
Market Cap
18.14M
Enterprise Value
-6.59M
1-Year Change
-4.54%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $18.14M, a decrease of -77.96%. That is a compound annual growth rate of -11.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 18.60M | -58.30% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 19.63M |
| Curis | 19.60M |
| Pasithea Therapeutics | 19.46M |
| Traws Pharma | 19.10M |
| Citius Pharmaceuticals | 18.99M |
| AEON Biopharma | 18.98M |
| OSR Holdings | 18.88M |
| Quince Therapeutics | 18.75M |